EMEA-002305-PIP01-17-M01
Key facts
| Active substance |
hydrocortisone (hemisuccinate)
|
| Therapeutic area |
Neonatology-Paediatric Intensive Care
|
| Decision number |
P/0358/2020
|
| PIP number |
EMEA-002305-PIP01-17-M01
|
| Pharmaceutical form(s) |
Powder and solvent for solution for injection
|
| Condition(s) / indication(s) |
Prevention of bronchopulmonary dysplasia
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Laboratoire Aguettant
E-mail: infoscientifique@aguettant.fr |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|